FindTrial
Sign In

MicroRNAs expression profiles associated with diagnosis and outcomes in different Syndrome types of psoriasis vulgaris

MicroRNAs expression profiles associated with diagnosis and outcomes in different Syndrome types of psoriasis vulgaris

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-11001660
Enrollment
Unknown
Registered
2011-11-04
Start date
2011-12-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

A:Optimization of Yinxieling
B:8ml venous blood was drawn out
C:8ml venous blood was drawn out
D:8ml venous blood was drawn out

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 to 70 years old; 2. Patients who meet the psoriasis vulgaris diagnosis creteria; 3. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women, and menorrhagia women; 2. Allergic to this drug ingredient; 3. Other types of psoriasis; 4. Taking steroids over the past 2 weeks, and / or oral administration of retinoic acid drugs, steroids outside over the past 1 week; 5. Associated with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system of primary and serious diseases, or mental illness; 6. Patients who judged by researchers as unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
MicroRNAs expression profiles;cytokine network;—

Countries

China

Contacts

Public ContactYuhong Yan
380031264@qq.com+86 15920395608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026